Expert Interview
Discussing positive results from the Tezspire Phase III WAYPOINT trial highlighting rapid and sustained effect in chronic rhinosinusitis with nasal polyps
Ticker(s): AZN, AMGNInstitution: Scripps Clinic
- Allergist/Immunologist & Director, Aspirin Exacerbated Respiratory Disease Clinic,Division of Allergy, Asthma and Immunology at the Scripps Clinic.
- Manages up to 50 CRS patients a month and considers CRS to be a focus of his practice.
- Was present at AAAAI conference when Waypoint data was presented.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
